Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Operating Expenses: 2021-2025

Historic Operating Expenses for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $69.4 million.

  • Core Scientific's Operating Expenses rose 60.58% to $69.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $193.2 million, marking a year-over-year increase of 58.92%. This contributed to the annual value of $122.3 million for FY2024, which is 20.96% up from last year.
  • Per Core Scientific's latest filing, its Operating Expenses stood at $69.4 million for Q3 2025, which was up 21.80% from $56.9 million recorded in Q2 2025.
  • Core Scientific's Operating Expenses' 5-year high stood at $105.6 million during Q2 2022, with a 5-year trough of $5.5 million in Q1 2021.
  • Over the past 3 years, Core Scientific's median Operating Expenses value was $26.8 million (recorded in 2024), while the average stood at $35.4 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first spiked by 1,179.17% in 2022, then tumbled by 75.36% in 2023.
  • Core Scientific's Operating Expenses (Quarterly) stood at $17.0 million in 2021, then soared by 145.12% to $41.6 million in 2022, then crashed by 37.16% to $26.1 million in 2023, then climbed by 2.67% to $26.8 million in 2024, then spiked by 60.58% to $69.4 million in 2025.
  • Its Operating Expenses was $69.4 million in Q3 2025, compared to $56.9 million in Q2 2025 and $40.1 million in Q1 2025.